Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effects of Polycystic Ovary Syndrome (PCOS), Sex Hormones, and Obesity on Circulating miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 Expression

14 Sept 2013

Abstract excerpt

CONTEXT: MicroRNAs (miRNAs) are small, noncoding RNA sequences that negatively regulate gene expression at the post-transcriptional level. miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 have been associated with metabolic disorders such as obesity and diabetes, which are also associated with polycystic ovary syndrome (PCOS). OBJECTIVE: We aimed to evaluate the effects of sex, sex hormones, and PCOS and their...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Menopause: Health Impacts and Treatments
Share to MicroRNA in disease regulation
Share to Ovarian function and disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24037889
DOI: 10.1210/jc.2013-2218

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effects of Polycystic Ovary Syndrome (PCOS), Sex Hormones, and Obesity on Circulating miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 ExpressionPMID 24037889Read ↗

Role of microRNA in the Pathogenesis of Polycystic Ovary SyndromeSemantic proximity Read ↗

Evaluation of circulating microRNA profiles in Brazilian women with polycystic ovary syndrome: A preliminary studySemantic proximity Read ↗

The Regulatory Role of MicroRNAs in Obesity and Obesity-Derived AilmentsSemantic proximity Read ↗

MicroRNAs as Biomarkers for Metabolic Disorders in Polycystic Ovary Syndrome (PCOS): A ReviewSemantic proximity Read ↗

Molecular diagnosis of polycystic ovary syndrome in obese and non-obese women by targeted plasma miRNA profilingSemantic proximity Read ↗

The Role of Serum MicroRNA-6767-5p as a Biomarker for the Diagnosis of Polycystic Ovary SyndromeSemantic proximity Read ↗

The Role of MicroRNA, Long Non-Coding RNA and Circular RNA in the Pathogenesis of Polycystic Ovary Syndrome: A Literature ReviewSemantic proximity Read ↗

Increased MicroRNA Levels in Women With Polycystic Ovarian Syndrome but Without Insulin Resistance: A Pilot Prospective StudySemantic proximity Read ↗

Biomarkers of obesity-mediated insulin resistance: focus on microRNAsSemantic proximity Read ↗

The role of circulating miRNAs in mechanism of action and prediction of therapeutic responses of metformin in polycystic ovarian syndromeSemantic proximity Read ↗

Hyperandrogenism and Metabolic Syndrome Are Associated With Changes in Serum-Derived microRNAs in Women With Polycystic Ovary SyndromeSemantic proximity Read ↗

microRNAs and long non‐coding RNAs as biomarkers for polycystic ovary syndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.